Cargando…
Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series
Mast cell activation syndrome (MCAS) is an immune disease with an estimated prevalence of 17%. Mast cell chemical mediators lead to heterogeneous multisystemic inflammatory and allergic manifestations. This syndrome is associated with various neurologic and psychiatric disorders, including headache,...
Autores principales: | Weinstock, Leonard B., Nelson, Renee M., Blitshteyn, Svetlana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672129/ https://www.ncbi.nlm.nih.gov/pubmed/38003876 http://dx.doi.org/10.3390/jpm13111562 |
Ejemplares similares
-
Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?
por: Afrin, Lawrence B., et al.
Publicado: (2022) -
Efficacy and toxicity of hydroxyurea in mast cell activation syndrome patients refractory to standard medical therapy: retrospective case series
por: Weinstock, Leonard B., et al.
Publicado: (2022) -
Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment
por: Weinstock, Leonard B, et al.
Publicado: (2018) -
Mast cell activation symptoms are prevalent in Long-COVID
por: Weinstock, Leonard B., et al.
Publicado: (2021) -
Mast cell activation syndrome
por: Ratner, Vicki
Publicado: (2015)